Viewing StudyNCT05406817



Ignite Creation Date: 2024-05-06 @ 5:42 PM
Last Modification Date: 2024-10-26 @ 2:34 PM
Study NCT ID: NCT05406817
Status: RECRUITING
Last Update Posted: 2024-07-11
First Post: 2022-06-01

Brief Title: Study of Radiolabeled Revumenib in Adults With Acute Leukemia
Sponsor: Syndax Pharmaceuticals
Organization: Syndax Pharmaceuticals

Conditions & Keywords Data

Conditions:
Name
Acute Leukemia
Keywords:
Name View
SNDX-5613 View
Acute Leukemia View
Refractory leukemia View
Relapsed leukemia View